查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1679355

北美数位病理学市场规模、份额、趋势分析报告（按应用、产品、最终用途、国家/地区、细分市场预测，2025 年至 2030 年）

North America Digital Pathology Market Size, Share & Trends Analysis Report By Application, By Product, By Type, By End Use, By Country, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10个工作天内

价格

北美数位病理学市场的成长和趋势

预计到 2030 年北美数位病理学市场规模将达到 6.939 亿美元，2025 年至 2030 年的复合年增长率为 7.8%。

推动市场发展的主要因素是癌症等慢性疾病的日益普及。由于癌症发生率高，病理学家需要能够为患者提供个人化治疗的资料。因此，数位病理因其多种优势逐渐被病理学家所选择，包括加快诊断速度、提高诊断准确性以及提供治疗建议以改善患者预后。

越来越多的合作协定旨在促进数位病理学在癌症诊断中的应用以及加速其发展，也是推动市场成长要素。近年来，人工智慧在数位病理学的应用日益受到重视。推动成长的因素包括降低医疗保健成本的需求不断增加、巨量资料在医疗保健中的重要性日益增加、精准医疗的采用率不断提高以及硬体成本下降。此外，医疗保健领域也越来越多地使用基于人工智慧的分析工具，以及该领域的大量资本投资进一步推动了市场的成长。

在冠状病毒大流行期间，对家庭工作站和安全临床资讯系统的需求激增，这些系统允许医疗保健专业人员远端读取影像并实现多学科护理团队之间的虚拟协作。疫情期间，该地区各组织病理学部门都面临人员减少、工作量增加的问题。数位病理学被视为病理学家面临的一些挑战的潜在解决方案，导致在冠状病毒大流行期间更多地采用疾病的数位化诊断。

2020 年 4 月，飞利浦宣布 FDA 已批准其 IntelliSite Pathology Solution 消费者监测仪的家用紧急豁免。暂时取消远端使用数位病理学的限制将有助于病理学家在家中获取全幻灯片影像并加快组织学病例的诊断。在 COVID-19 之前，采用 DP 进行跨站点工作流程的病理实验室报告协作得到改善，平均生产力提高了 21.0%，营运效率提高了 13.0%。预计这些倡议将推动市场成长。

北美数位病理市场报告重点

  • 北美数位病理学市场目前正在经历显着且加速的成长。
  • 2024 年，设备部门占最大份额，为 52.07%。
  • 2024 年，人类病理学领域占最大份额。
  • 对于 2024 年的预测期，学术研究领域将占据市场主导地位。
  • 2024 年，美国数位病理学市场占据各地区最大市场。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场体系展望
    • 母市场分析
    • 辅助市场分析
  • 北美数位病理学市场-市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场问题分析
  • 北美数位病理学市场分析工具：波特五力分析
    • 供应商的议价能力
    • 买家的议价能力
    • 替代威胁
    • 来自新进入者的威胁
    • 竞争对手之间的竞争
  • PESTLE分析
    • 政治
    • 经济与社会
    • 科技
    • 环境
    • 合法的
  • 使用案例和见解
  • COVID-19 的影响

第 4 章北美数位病理学市场：按产品分類的估计和趋势分析

  • 北美数位病理学市场（按产品划分）：关键要点
  • 北美数位病理学市场：2024 年和 2030 年产品趋势和市场占有率分析
  • 软体
  • 装置
    • 扫描器
    • 幻灯片管理系统
  • 储存系统

第五章北美数位病理学市场类型、估值与趋势分析

  • 北美数位病理学市场（按类型）：关键要点
  • 北美数位病理学市场：2024 年和 2030 年类型趋势和市场占有率分析
  • 动物病理学
  • 人体病理学

第六章北美数位病理学市场：按应用的估计和趋势分析

  • 北美数位病理学市场（按应用）关键要点
  • 北美数位病理学市场：2024 年和 2030 年应用趋势和市场占有率分析
  • 药物研发
  • 学术研究
  • 疾病诊断
    • 癌细胞检测
    • 其他的

7. 北美数位病理学市场-最终用途、估计与趋势分析

  • 北美数位病理学市场（按最终用途划分）：关键要点
  • 北美数位病理学市场：2024 年和 2030 年最终用途趋势和市场占有率分析
  • 医院
  • 生物技术和製药公司
  • 诊断实验室
  • 学术研究所

第 8 章。北美数位病理学市场：按国家/地区分類的估计和趋势分析

  • 北美数位病理学市场：2024 年和 2030 年区域趋势分析
  • 区域市场仪表板
  • 区域市场概况
    • 北美洲

第九章竞争格局

  • 公司分类
  • 竞争性市场参与策略
  • 私人公司/供应商（按国家/地区）
  • 2024 年公司市场占有率/地位分析
  • 公司简介/上市公司
    • Leica Biosystems Nussloch GmbH（Danaher）
    • Hamamatsu Photonics, Inc
    • Koninklijke Philips NV
    • Olympus Corporation
    • F. Hoffmann-La Roche Ltd
    • Mikroscan Technologies, Inc
    • Inspirata, Inc.
    • Epredia（3DHISTECH Ltd.）
    • Huron Technologies International Inc.
    • CellaVision
    • Morphle Labs, Inc
    • Bionovation BIoTech, Inc
Product Code: GVR-4-68039-288-0

North America Digital Pathology Market Growth & Trends:

The North America digital pathology market size is expected to reach USD 693.9 million in 2030 and is expected to grow at a CAGR of 7.8% from 2025 to 2030. The market is predominantly driven by the growing prevalence of chronic diseases such as cancer. As a consequence of the high prevalence of cancer, pathologists require data that facilitate personalizing therapy for patients. Hence, digital pathology is progressively being selected by pathologists as it has various benefits including accelerated diagnosis rate, diagnostic accuracy, and offers therapeutic recommendations to improve patient outcomes.

The growing number of collaborative agreements to develop as well as expedite the adoption of digital pathology in cancer diagnostics serves as a key growth factor contributing to the market. The use of artificial intelligence in digital pathology has gained momentum in the past years. The increasing need for lowering healthcare costs, increasing importance of big data in healthcare, rising adoption of precision medicine, and declining hardware costs are some factors driving the growth. In addition, increasing usage of artificial intelligence-based analytical tools in healthcare and high capital investments in this field are further propelling the market growth.

During the coronavirus outbreak, the exponential need for home-based workstations and safe clinical informatics systems allowing healthcare professionals to read images remotely and enabling virtual collaboration between their multi-disciplinary care teams has increased. Various histopathology departments in the region faced a reducing workforce and increasing workload during the pandemic. Digital pathology considered being the potential solution for some of the challenges faced by the pathologist, there is an increase in the adoption of digital diagnosis of disease during coronavirus outbreak.

In April 2020, Philips announced that the FDA granted a waiver for home use of consumer monitors with the company's IntelliSite Pathology Solution during the emergency. The temporary exemption of restrictions on remote use of the digital pathology helps pathologists to access whole slide images from home and fasten the diagnosis of histology cases. Some pathology labs that have adopted DP in their workflows across different sites pre-COVID-19, reported improved collaboration, and an average productivity gain of 21.0% with operation efficiency increased by 13.0%. These types of initiatives are anticipated to fuel market growth.

North America Digital Pathology Market Report Highlights:

  • North America digital pathology market is currently experiencing significant growth, at an accelerating pace
  • The device segment held the largest share of 52.07% in 2024
  • The human pathology segment held the largest share in 2024
  • The academic research segment dominated the market in 2024he forecast period
  • The digital pathology market in the U.S. dominated the regional market with the largest share in 2024

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database:
    • 1.3.2. Gvr's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research:
    • 1.3.5. Details Of Primary Research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for Primary Interviews in Europe
      • 1.3.5.3. Data for Primary Interviews in APAC
      • 1.3.5.4. Data for Primary Interviews in Latin America
      • 1.3.5.5. Data for Primary Interviews in MEA
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis
    • 1.6.2. Top Down Market Estimation
    • 1.6.3. CAGR Calculation
    • 1.6.4. Key Report Updates
  • 1.7. List of Secondary Sources
  • 1.8. List of Abbreviations
  • 1.9. Report Objectives
    • 1.9.1. Objective - 1
    • 1.9.2. Objective - 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segmental Snapshot
  • 2.3. Competitive Insights Snapshot

Chapter 3. Market Variables, Trends, and Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Analysis
    • 3.1.2. Ancillary Market Analysis
  • 3.2. North America Digital Pathology Market- Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Higher cost-efficiency
      • 3.2.1.3. Rapid technological advancements in the overall digital pathology market
        • 3.2.1.3.1. Competitive Factors and Strategies
        • 3.2.1.3.2. List of Top Notable Funded Digital Pathology Companies
        • 3.2.1.3.3. Top 10 Vendor - by Total Funding from 2014 - 2021 (Potential vendors for collabrations)
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of skilled professionals
      • 3.2.2.2. High cost of implementing digital pathology solutions
    • 3.2.3. Market Challenges Analysis
  • 3.3. North America Digital Pathology Market Analysis Tools: Porters Five Forces
    • 3.3.1. Bargaining power of the suppliers
    • 3.3.2. Bargaining power of the buyers
    • 3.3.3. Threats of substitution
    • 3.3.4. Threats from new entrants
    • 3.3.5. Competitive rivalry
  • 3.4. PESTLE Analysis
    • 3.4.1. Political landscape
    • 3.4.2. Economic and Social landscape
    • 3.4.3. Technological landscape
    • 3.4.4. Environmental landscape
    • 3.4.5. Legal landscape
  • 3.5. Case Studies & Inisghts
  • 3.6. Impact of COVID 19

Chapter 4. North America Digital Pathology Market: Product Estimates & Trend Analysis

  • 4.1. North America Digital Pathology Market, Product Type: Key Takeaways
  • 4.2. North America Digital Pathology Market: Product Type Movement & Market Share Analysis, 2024 & 2030
  • 4.3. Software
    • 4.3.1. Software Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Devices
    • 4.4.1. Devices Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 4.4.2. Scanners
      • 4.4.2.1. Scanners market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.4.3. Slide Management System
      • 4.4.3.1. Slide management system market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5. Storage Systems
    • 4.5.1. Storage Systems Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. North America Digital Pathology Market: Type Estimates & Trend Analysis

  • 5.1. North America Digital Pathology Market, by Type: Key Takeaways
  • 5.2. North America Digital Pathology Market: Type Movement & Market Share Analysis, 2024 & 2030
  • 5.3. Veterinary Pathology
    • 5.3.1. Veterinary Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Human Pathology
    • 5.4.1. Human Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. North America Digital Pathology Market: Application Estimates & Trend Analysis

  • 6.1. North America Digital Pathology Market, Application Type: Key Takeaways
  • 6.2. North America Digital Pathology Market: Application Movement & Market Share Analysis, 2024 & 2030
  • 6.3. Drug Discovery & Development
    • 6.3.1. Drug Discovery & Development Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Academic Research
    • 6.4.1. Academic Research Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Disease Diagnosis
    • 6.5.1. Disease Diagnosis Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. Cancer Cell Detection
      • 6.5.2.1. Cancer Cell Detection Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.3. Others
      • 6.5.3.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. North America Digital Pathology Market: End Use Estimates & Trend Analysis

  • 7.1. North America Digital Pathology Market, By End Use: Key Takeaways
  • 7.2. North America Digital Pathology Market: End Use Movement & Market Share Analysis, 2024 & 2030
  • 7.3. Hospitals
    • 7.3.1. Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Biotech & Pharma Companies
    • 7.4.1. Biotech & Pharma Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Diagnostics Labs
    • 7.5.1. Diagnostics Labs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Academic & Research Institutes
    • 7.6.1. Academic & Research Institutes Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. North America Digital Pathology Market: Country Estimates & Trend Analysis

  • 8.1 North America Digital Pathology Market: Regional Movement Analysis, 2024 & 2030
  • 8.2 Regional Market Dashboard
  • 8.3 Regional Market Snapshot
    • 8.3.1 North America
      • 8.3.1.1 North America Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.3.1.2 U.S.
        • 8.3.1.2.1 Key Country Dynamics
        • 8.3.1.2.2 Competitive Scenario
        • 8.3.1.2.3 Regulatory Framework
        • 8.3.1.2.4 Reimbursement Scenario
        • 8.3.1.2.5 U.S. Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.3.1.3 Canada
        • 8.3.1.3.1 Key Country Dynamics
        • 8.3.1.3.2 Competitive Scenario
        • 8.3.1.3.3 Regulatory Framework
        • 8.3.1.3.4 Reimbursement Scenario
        • 8.3.1.3.5 Canada Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.3.1.4 Mexico
        • 8.3.1.4.1 Key Country Dynamics
        • 8.3.1.4.2 Competitive Scenario
        • 8.3.1.4.3 Regulatory Framework
        • 8.3.1.4.4 Reimbursement Scenario
        • 8.3.1.4.5 Mexico Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Competitive Market Entry Strategies
  • 9.3. Private Companies/ Vendors, By Country/Region
  • 9.4. Company Market Share/Position Analysis, 2024
  • 9.5. Company Profiles/Listing
    • 9.5.1. Leica Biosystems Nussloch GmbH (Danaher)
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Hamamatsu Photonics, Inc
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Koninklijke Philips N.V.
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. Olympus Corporation
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. F. Hoffmann-La Roche Ltd
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Mikroscan Technologies, Inc
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Inspirata, Inc.
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Epredia (3DHISTECH Ltd.)
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Huron Technologies International Inc.
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. CellaVision
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives
    • 9.5.11. Morphle Labs, Inc
      • 9.5.11.1. Overview
      • 9.5.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.5.11.3. Product Benchmarking
      • 9.5.11.4. Strategic Initiatives
    • 9.5.12. Bionovation Biotech, Inc
      • 9.5.12.1. Overview
      • 9.5.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.5.12.3. Product Benchmarking
      • 9.5.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America Digital Pathology Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 North America Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 North America Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 North America Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 North America Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 8 North America Digital Pathology Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 North America Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 11 North America Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 12 North America Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 15 U.S. Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 16 U.S. Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 18 Canada Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 19 Canada Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Canada Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 21 Mexico Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 22 Mexico Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Mexico Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Mexico Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 North America Digital pathology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 North America Digital pathology market: Product movement analysis
  • Fig. 17 North America Digital pathology market: Product segment dashboard
  • Fig. 18 North America Digital pathology market product outlook: Key takeaways
  • Fig. 19 Software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Integrated Software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Standalone Software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Device market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Storage system market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 North America Digital pathology market: Type movement analysis
  • Fig. 25 North America Digital pathology market: Type segment dashboard
  • Fig. 26 North America Digital pathology market type outlook: Key takeaways
  • Fig. 27 Human digital pathology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Veterinary digital pathology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 North America Digital pathology market: Application movement analysis
  • Fig. 30 North America Digital pathology market: Application segment dashboard
  • Fig. 31 North America Digital pathology market application outlook: Key takeaways
  • Fig. 32 North America Drug discovery & development market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Academic research market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Disease diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 North America Digital pathology market: End-use movement analysis
  • Fig. 36 North America Digital pathology market: End-use segment dashboard
  • Fig. 37 North America Digital pathology market end-use outlook: Key takeaways
  • Fig. 38 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Biotech & pharma companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Diagnostic labs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Academic &research institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Regional outlook, 2024 & 2030
  • Fig. 43 Regional market dashboard
  • Fig. 44 Regional market place: Key takeaways
  • Fig. 45 North America, SWOT
  • Fig. 46 North America Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 48 Canada Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico Digital pathology market, 2018 - 2030 (USD Million)